BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 24002146)

  • 1. Calcium hydroxylapatite filler: an overview of safety and tolerability.
    Pavicic T
    J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
    Emer J; Sundaram H
    J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation.
    Lizzul PF; Narurkar VA
    J Drugs Dermatol; 2010 May; 9(5):446-50. PubMed ID: 20480786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium hydroxylapatite: A review on safety and complications.
    Kadouch JA
    J Cosmet Dermatol; 2017 Jun; 16(2):152-161. PubMed ID: 28247924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
    Tzikas TL
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
    Sadick NS; Katz BE; Roy D
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
    Marmur ES; Taylor SC; Grimes PE; Boyd CM; Porter JP; Yoo JY
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1641-5. PubMed ID: 19708876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation.
    Jansen DA; Graivier MH
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting results with hydroxylapatite (Radiesse) facial filler.
    Jacovella PF; Peiretti CB; Cunille D; Salzamendi M; Schechtel SA
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):15S-21S. PubMed ID: 16936540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds.
    Carruthers A; Liebeskind M; Carruthers J; Forster BB
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S78-84. PubMed ID: 18547186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand recontouring with calcium hydroxylapatite (Radiesse).
    Edelson KL
    J Cosmet Dermatol; 2009 Mar; 8(1):44-51. PubMed ID: 19250166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis.
    Berlin AL; Hussain M; Goldberg DJ
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S64-7. PubMed ID: 18547184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semipermanent and permanent injectable fillers.
    Jones DH
    Dermatol Clin; 2009 Oct; 27(4):433-44, vi. PubMed ID: 19850193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of injectable CaHA for the treatment of mid-face volume loss.
    Beer K; Yohn M; Cohen JL
    J Drugs Dermatol; 2008 Apr; 7(4):359-66. PubMed ID: 18459517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of calcium hydroxylapatite in the upper third of the face: Retrospective analysis of techniques, dilutions and adverse events.
    Van Loghem JAJ
    J Cosmet Dermatol; 2018 Dec; 17(6):1025-1030. PubMed ID: 30362225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results.
    Bass LS; Smith S; Busso M; McClaren M
    Aesthet Surg J; 2010 Mar; 30(2):235-8. PubMed ID: 20442101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.
    van Loghem J; Funt D; Pavicic T; Goldie K; Yutskovskaya Y; Fabi S; Siebenga P; Thuis J; Hkeik J; Kadouch J; Prager W; Azib N; Casabona G; Dayan S; Bay Aguilera S; Snozzi P; Saeed P
    J Cosmet Dermatol; 2020 Nov; 19(11):2845-2858. PubMed ID: 32185876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of Radiesse/calcium hydroxylapatite and carboxymethylcellulose: evidence and recommendations for treatment of the face.
    Guida S; Galadari H
    Int J Dermatol; 2024 Feb; 63(2):150-160. PubMed ID: 37897174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium hydroxylapatite (Radiesse): safety, techniques and pain reduction.
    Busso M
    J Drugs Dermatol; 2009 Oct; 8(10 Suppl):s21-3. PubMed ID: 19891118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of injectable soft tissue filler complications.
    Sclafani AP; Fagien S
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1672-80. PubMed ID: 19807763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.